Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
<p>Abstract</p> <p>Background</p> <p>Although numerous chemotherapeutic agents have been tested, the role of systemic chemotherapy for hepatocellular carcinoma (HCC) has not been clarified. New therapeutic strategies are thus needed to improve outcomes, and we designed...
| المؤلفون الرئيسيون: | , , , , , , , , , , , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
BMC
2006-01-01
|
| سلاسل: | BMC Cancer |
| الوصول للمادة أونلاين: | http://www.biomedcentral.com/1471-2407/6/3 |